Gloria Salvo

14PUBLICATIONS
13CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Cancer diagnosisPredictive and prognostic markersSurgeryOncology and carcinogenesis not elsewhere classified
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (14)

|Dec 15, 2023
Impact of pelvic radiation therapy in patients with early neuroendocrine cervical carcinoma and no residual disease in the radical hysterectomy specimen: a NeCTuR study.

Nilsha Khurana, Michael Frumovitz, Alejandra Flores Legarreta

|Oct 24, 2023
PET/CT scan improves detection of metastatic disease compared with CT scan alone in women with high-grade neuroendocrine cervical cancer: a NeCTuR study.

Michael Frumovitz, Ajaykumar C Morani, Aatiqah Aziz

|Aug 11, 2023
Clinicopathologic characteristics, oncologic outcomes, and prognostic factors in neuroendocrine cervical carcinoma: a Neuroendocrine Cervical Tumor Registry study.

Gloria Salvo, Alejandra Flores Legarreta, Preetha Ramalingam

|Feb 22, 2023
RB1 alteration and poor prognosis in women with high-grade neuroendocrine carcinoma of the uterine cervix: a NeCTuR study.

Alejandra Flores Legarreta, Gloria Salvo, Naomi R Gonzales

|Feb 10, 2021
Role of radical hysterectomy in patients with early-stage high-grade neuroendocrine cervical carcinoma: a NeCTuR study.

Gloria Salvo, Preetha Ramalingam, Alejandra Flores Legarreta

|Jul 31, 2020
Evaluation of PARP and PDL-1 as potential therapeutic targets for women with high-grade neuroendocrine carcinomas of the cervix.

Matthew Ryan Carroll, Preetha Ramalingam, Gloria Salvo

Pageof 3